エンブレルの世界市場レポート 2025年：疫学、パイプライン分析、市場インサイトと予測

エンブレルの市場規模は、今後数年間で力強い成長が見込まれます。2029年には年間平均成長率（CAGR）6%で209億3,090万米ドルに成長します。この予測期間における成長は、複数の適応症におけるエンブレルの使用拡大、生物製剤や関節リウマチ（ra）治療に対する政府支援の増加、自己免疫疾患に対する意識の高まり、一般人口における炎症性疾患に対する意識の高まり、バイオシミラーの利用可能性の増加、エンブレルの認知促進などに起因しています。予測期間における主要動向としては、自己免疫疾患管理のためのデジタルヘルスケアツール、製薬企業間の世界のパートナーシップ、患者のコンプライアンス向上のための長時間作用型注射製剤の開発、自己免疫疾患治療開発における人工知能の統合、生物製剤の代替デリバリーシステムの開発などが挙げられます。

自己免疫疾患の有病率の増加は、エンブレル市場の拡大を促進すると予想されています。自己免疫疾患は、免疫系が誤って身体の健康な細胞や組織を攻撃し、炎症や様々な臓器への損傷を引き起こすことで発生します。このような有病率の増加は、遺伝的素因、環境的誘因、ライフスタイルや免疫系行動の変化などの要因に関連しています。自己免疫症例の増加は、関節リウマチや乾癬性関節炎などの炎症性疾患を管理するエンブレルのような治療に対する需要を押し上げています。例えば、2022年8月、国立医療図書館はCOVID-19ワクチン接種に関連した自己免疫疾患の症例を約928例報告しました。このうち81.5％（756例）は新たに発症した自己免疫疾患で、症状は通常ワクチン接種後8日目に現れました。女性は症例の53.6％を占め、年齢中央値は48歳でした。このように、自己免疫疾患の有病率の増加は、エンブレル市場を前進させると予測されます。

エンブレル市場の重要な動向は、競合を強化するために薬事承認を取得することです。医薬品承認プロセスでは、規制当局が臨床検査データに基づいて新薬の安全性、有効性、品質を評価し、承認します。例えば、2023年10月、米国のバイオ医薬品会社であるAmgen Inc.は、活動性の若年性乾癬性関節炎（JPsA）の2歳以上の小児の治療としてエンブレルのFDA承認を発表しました。この承認は、成人の関節症性乾癬（PsA）、関節リウマチ（RA）、乾癬患者を対象とした包括的な安全性・有効性検査を通じて実証された、腫瘍壊死因子遮断薬としてのエタネルセプトのユニークな特性を強調するものです。また、活動性の若年性特発性関節炎（JIA）と乾癬の小児患者における使用を支持する薬剤動態学的（PK）データも含まれています。若年性特発性関節炎（JPsA）に対する推奨用量は体重ベースであり、週1回皮下注射にて投与します。

目次

第1章 エグゼクティブサマリー

第2章 市場の特徴

第3章 バイオ医薬品市場における製品特性

• 分子タイプ
• 投与経路（ROA）
• 作用機序（MOA）
• 安全性と有効性

第4章 市場動向と戦略

第5章 市場：金利、インフレ、地政学、貿易戦争と関税、コロナ禍と回復が市場に与える影響を含むマクロ経済シナリオ

第6章 世界の成長分析と戦略分析フレームワーク

• 世界のエンブレル：PESTEL分析（政治、社会、技術、環境、法的要因、促進要因と抑制要因）
• 最終用途産業の分析
• 世界のエンブレル市場：成長率分析
• 世界のエンブレル市場の実績：規模と成長、2019～2024年
• 世界のエンブレル市場の予測：規模と成長、2024～2029年、2034年
• 世界のエンブレル：総潜在市場規模（TAM）

第7章 世界の価格分析と予測

第8章 市場セグメンテーション

• 世界のエンブレル市場：製品別、実績と予測、2019～2024年、2024～2029年、2034年
• 注射液
• プレフィルドシリンジ
• 併用療法
• 徐放性製剤
• バイオシミラー
• 世界のエンブレル市場：流通チャネル別、実績と予測、2019～2024年、2024～2029年、2034年
• 病院薬局
• 小売薬局
• オンライン薬局
• 世界のエンブレル市場：用途別、実績と予測、2019～2024年、2024～2029年、2034年
• 関節リウマチ
• 若年性特発性関節炎
• 乾癬性関節炎
• 強直性脊椎炎
• その他

第9章 臨床適応症の世界的疫学

• 薬剤の副作用
• 臨床適応症の発症率と有病率

第10章 地域別・国別分析

• 世界のエンブレル市場：地域別、実績と予測、2019～2024年、2024～2029年、2034年
• 世界のエンブレル市場：国別、実績と予測、2019～2024年、2024～2029年、2034年

第11章 アジア太平洋市場

第12章 中国市場

第13章 インド市場

第14章 日本市場

第15章 オーストラリア市場

第16章 韓国市場

第17章 西欧市場

第18章 英国市場

第19章 ドイツ市場

第20章 フランス市場

第21章 東欧市場

第22章 北米市場

第23章 米国市場

第24章 カナダ市場

第25章 南米市場

第26章 中東市場

第27章 アフリカ市場

第28章 競合情勢と企業プロファイル

• エンブレル市場：競合情勢
• エンブレル市場：企業プロファイル
  • Amgen Inc.

第29章 世界市場：パイプライン分析

第30章 世界の市場競合ベンチマーキングとダッシュボード

第31章 主要な合併と買収

第32章 最近の市場動向

第33章 市場の潜在力が高い国、戦略

• エンブレル市場、2029年：新たな機会を提供する国
• エンブレル市場、2029年：新たな機会を提供するセグメント
• エンブレル市場、2029年：成長戦略
  • 市場動向による戦略
  • 競合の戦略

第34章 付録

Enbrel (generic name: etanercept) is a prescription drug used to manage various autoimmune disorders by suppressing the immune system. This biologic medication functions by blocking tumor necrosis factor (TNF), a substance that contributes to inflammation in conditions like rheumatoid arthritis and psoriasis.

Note that the outlook for this market is being affected by rapid changes in trade relations and tariffs globally. The report will be updated prior to delivery to reflect the latest status, including revised forecasts and quantified impact analysis. The report's Recommendations and Conclusions sections will be updated to give strategies for entities dealing with the fast-moving international environment.

Enbrel is available in several forms, including injectable solutions, prefilled syringes, combination therapies, extended-release formulations, and biosimilars. Injectable solutions are liquid medications administered via injection. These products are distributed through hospital pharmacies, retail pharmacies, and online pharmacies and are used to treat rheumatoid arthritis, juvenile idiopathic arthritis, psoriatic arthritis, ankylosing spondylitis, and other related conditions.

The enbrel market research report is one of a series of new reports from The Business Research Company that provides enbrel market statistics, including enbrel industry global market size, regional shares, competitors with a enbrel market share, detailed enbrel market segments, market trends and opportunities, and any further data you may need to thrive in the enbrel industry. This enbrel market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

The enbrel market size is expected to see strong growth in the next few years. It will grow to $20,930.9 million in 2029 at a compound annual growth rate (CAGR) of 6%. The growth in the forecast period can be attributed to growing use of enbrel in multiple indications, increasing government support for biologics and rheumatoid arthritis (ra) treatment, growing awareness of autoimmune diseases, rising awareness of inflammatory diseases in the general population, increasing availability of biosimilars, promoting awareness of enbrel. Major trends in the forecast period include digital healthcare tools for managing autoimmune diseases, global partnerships between pharmaceutical companies, development of long-acting injectable formulations for better patient compliance, integration of artificial intelligence in drug development for autoimmune diseases, development of alternative delivery systems for biologic drugs.

The growing prevalence of autoimmune conditions is anticipated to fuel the expansion of the Enbrel market. Autoimmune conditions arise when the immune system erroneously attacks the body's healthy cells and tissues, causing inflammation and damage to various organs. This increasing prevalence is linked to factors such as genetic predisposition, environmental triggers, and lifestyle or immune system behavior changes. The rising number of autoimmune cases boosts the demand for treatments like Enbrel, which manages inflammatory diseases such as rheumatoid arthritis and psoriatic arthritis. For example, in August 2022, the National Library of Medicine reported approximately 928 cases of autoimmune conditions associated with COVID-19 vaccination in 2022. Among these, 81.5% (756 cases) were new-onset autoimmune diseases, with symptoms typically appearing eight days post-vaccination. Women accounted for 53.6% of the cases, with a median age of 48. Thus, the growing prevalence of autoimmune conditions is projected to drive the Enbrel market forward.

A significant trend in the Enbrel market involves obtaining regulatory drug approvals to enhance competitive positioning. Drug approval processes involve regulatory authorities assessing and authorizing new drugs for safety, efficacy, and quality based on clinical trial data. For instance, in October 2023, Amgen Inc., a US-based biopharmaceutical company, announced FDA approval for Enbrel to treat children aged two and older with active juvenile psoriatic arthritis (JPsA). This approval underscores the unique attributes of etanercept as a tumor necrosis factor blocker, demonstrated through comprehensive safety and efficacy studies in adults with psoriatic arthritis (PsA), rheumatoid arthritis (RA), and psoriasis. It also includes pharmacokinetic (PK) data supporting its use in pediatric patients with active juvenile idiopathic arthritis (JIA) and psoriasis. The recommended dosage for juvenile PsA (JPsA) is weight-based and administered via weekly subcutaneous injection.

In November 2023, Amazon Web Services Inc. (AWS), a US-based cloud computing company, partnered with Amgen Inc. to enhance production output and expedite global delivery of medications to patients. Through this collaboration, Amgen is utilizing AWS to develop generative AI-based solutions to accelerate the discovery, development, and manufacturing processes for medicines aimed at treating serious illnesses. Amgen Inc. is a US-based producer of Enbrel.

The key copanies operating in the enbrel market is Amgen Inc.

North America was the largest region in the enbrel market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in enbrel report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East and Africa.

The countries covered in the enbrel market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

The enbrel market consists of sales of monoclonal antibodies, cancer immunotherapy drugs and biosimilars. Values in this market are 'factory gate' values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

Enbrel Global Market Report 2025 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses on enbrel market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

• Gain a truly global perspective with the most comprehensive report available on this market covering 15 geographies.
• Assess the impact of key macro factors such as conflict, pandemic and recovery, inflation and interest rate environment and the 2nd Trump presidency.
• Create regional and country strategies on the basis of local data and analysis.
• Identify growth segments for investment.
• Outperform competitors using forecast data and the drivers and trends shaping the market.
• Understand customers based on the latest market shares.
• Benchmark performance against key competitors.
• Suitable for supporting your internal and external presentations with reliable high quality data and analysis
• Report will be updated with the latest data and delivered to you within 2-3 working days of order along with an Excel data sheet for easy data extraction and analysis.
• All data from the report will also be delivered in an excel dashboard format.

Where is the largest and fastest growing market for enbrel ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward? The enbrel market global report from the Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.

• The market characteristics section of the report defines and explains the market.
• The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
• The forecasts are made after considering the major factors currently impacting the market. These include:

The forecasts are made after considering the major factors currently impacting the market. These include the Russia-Ukraine war, rising inflation, higher interest rates, and the legacy of the COVID-19 pandemic.

• Market segmentations break down the market into sub markets.
• The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth. It covers the growth trajectory of COVID-19 for all regions, key developed countries and major emerging markets.
• The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
• The trends and strategies section analyses the shape of the market as it emerges from the crisis and suggests how companies can grow as the market recovers.

Scope

• Markets Covered:1) By Product: Injectable Solution; Prefilled Syringes; Combination Therapy; Extended Release Formulations; Biosimilars
• 2) By Distribution Channel: Hospital Pharmacies; Retail Pharmacies; Online Pharmacies
• 3) By Application: Rheumatoid Arthritis; Juvenile Idiopathic Arthritis; Psoriatic Arthritis; Ankylosing Spondylitis; Other Applications
• Companies Mentioned: Amgen Inc.
• Countries: Australia, India, China, South Korea, Japan, UK, France, Germany, USA, Canada
• Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
• Time series: Five years historic and ten years forecast.
• Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,
• Data segmentations: country and regional historic and forecast data, market share of competitors, market segments.
• Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
• Delivery Format: PDF, Word and Excel Data Dashboard.

Table of Contents

1. Executive Summary

2. Enbrel Market Characteristics

3. Enbrel Market Biologic Drug Characteristics

• 3.1. Molecule Type
• 3.2. Route Of Administration (ROA)
• 3.3. Mechanism Of Action (MOA)
• 3.4. Safety And Efficacy

4. Enbrel Market Trends And Strategies

5. Enbrel Market - Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics, Trade Wars and Tariffs, And Covid And Recovery On The Market

6. Global Enbrel Growth Analysis And Strategic Analysis Framework

• 6.1. Global Enbrel PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)
• 6.2. Analysis Of End Use Industries
• 6.3. Global Enbrel Market Growth Rate Analysis
• 6.4. Global Enbrel Historic Market Size and Growth, 2019 - 2024, Value ($ Million)
• 6.5. Global Enbrel Forecast Market Size and Growth, 2024 - 2029, 2034F, Value ($ Million)
• 6.6. Global Enbrel Total Addressable Market (TAM)

7. Global Enbrel Pricing Analysis & Forecasts

8. Enbrel Market Segmentation

• 8.1. Global Enbrel Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
• Injectable Solution
• Prefilled Syringes
• Combination Therapy
• Extended Release Formulations
• Biosimilars
• 8.2. Global Enbrel Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
• Hospital Pharmacies
• Retail Pharmacies
• Online Pharmacies
• 8.3. Global Enbrel Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
• Rheumatoid Arthritis
• Juvenile Idiopathic Arthritis
• Psoriatic Arthritis
• Ankylosing Spondylitis
• Other Applications

9. Global Enbrel Epidemiology Of Clinical Indications

• 9.1. Drug Side Effects
• 9.2. Incidence And Prevalence of Clinical Indications

10. Enbrel Market Regional And Country Analysis

• 10.1. Global Enbrel Market, Split By Region, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
• 10.2. Global Enbrel Market, Split By Country, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

11. Asia-Pacific Enbrel Market

• 11.1. Asia-Pacific Enbrel Market Overview
• Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
• 11.2. Asia-Pacific Enbrel Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
• 11.3. Asia-Pacific Enbrel Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
• 11.4. Asia-Pacific Enbrel Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

12. China Enbrel Market

• 12.1. China Enbrel Market Overview
• 12.2. China Enbrel Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Million
• 12.3. China Enbrel Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Million
• 12.4. China Enbrel Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Million

13. India Enbrel Market

• 13.1. India Enbrel Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
• 13.2. India Enbrel Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
• 13.3. India Enbrel Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

14. Japan Enbrel Market

• 14.1. Japan Enbrel Market Overview
• 14.2. Japan Enbrel Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
• 14.3. Japan Enbrel Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
• 14.4. Japan Enbrel Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

15. Australia Enbrel Market

• 15.1. Australia Enbrel Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
• 15.2. Australia Enbrel Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
• 15.3. Australia Enbrel Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

16. South Korea Enbrel Market

• 16.1. South Korea Enbrel Market Overview
• 16.2. South Korea Enbrel Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
• 16.3. South Korea Enbrel Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
• 16.4. South Korea Enbrel Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

17. Western Europe Enbrel Market

• 17.1. Western Europe Enbrel Market Overview
• 17.2. Western Europe Enbrel Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
• 17.3. Western Europe Enbrel Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
• 17.4. Western Europe Enbrel Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

18. UK Enbrel Market

• 18.1. UK Enbrel Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
• 18.2. UK Enbrel Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
• 18.3. UK Enbrel Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

19. Germany Enbrel Market

• 19.1. Germany Enbrel Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
• 19.2. Germany Enbrel Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
• 19.3. Germany Enbrel Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

20. France Enbrel Market

• 20.1. France Enbrel Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
• 20.2. France Enbrel Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
• 20.3. France Enbrel Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

21. Eastern Europe Enbrel Market

• 21.1. Eastern Europe Enbrel Market Overview
• 21.2. Eastern Europe Enbrel Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
• 21.3. Eastern Europe Enbrel Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
• 21.4. Eastern Europe Enbrel Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

22. North America Enbrel Market

• 22.1. North America Enbrel Market Overview
• 22.2. North America Enbrel Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
• 22.3. North America Enbrel Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
• 22.4. North America Enbrel Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

23. USA Enbrel Market

• 23.1. USA Enbrel Market Overview
• 23.2. USA Enbrel Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
• 23.3. USA Enbrel Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
• 23.4. USA Enbrel Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

24. Canada Enbrel Market

• 24.1. Canada Enbrel Market Overview
• 24.2. Canada Enbrel Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
• 24.3. Canada Enbrel Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
• 24.4. Canada Enbrel Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

25. South America Enbrel Market

• 25.1. South America Enbrel Market Overview
• 25.2. South America Enbrel Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
• 25.3. South America Enbrel Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
• 25.4. South America Enbrel Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

26. Middle East Enbrel Market

• 26.1. Middle East Enbrel Market Overview
• 26.2. Middle East Enbrel Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
• 26.3. Middle East Enbrel Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
• 26.4. Middle East Enbrel Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

27. Africa Enbrel Market

• 27.1. Africa Enbrel Market Overview
• 27.2. Africa Enbrel Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
• 27.3. Africa Enbrel Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
• 27.4. Africa Enbrel Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

28. Enbrel Market Competitive Landscape And Company Profiles

• 28.1. Enbrel Market Competitive Landscape
• 28.2. Enbrel Market Company Profiles
  • 28.2.1. Amgen Inc. Overview, Products and Services, Strategy and Financial Analysis

29. Global Enbrel Market Pipeline Analysis

• 29.1. High Level Clinic Trail Information

30. Global Enbrel Market Competitive Benchmarking And Dashboard

31. Key Mergers And Acquisitions In The Enbrel Market

32. Recent Developments In The Enbrel Market

33. Enbrel Market High Potential Countries, Segments and Strategies

• 33.1 Enbrel Market In 2029 - Countries Offering Most New Opportunities
• 33.2 Enbrel Market In 2029 - Segments Offering Most New Opportunities
• 33.3 Enbrel Market In 2029 - Growth Strategies
  • 33.3.1 Market Trend Based Strategies
  • 33.3.2 Competitor Strategies

34. Appendix

• 34.1. Abbreviations
• 34.2. Currencies
• 34.3. Historic And Forecast Inflation Rates
• 34.4. Research Inquiries
• 34.5. The Business Research Company
• 34.6. Copyright And Disclaimer